Supernus Pharma's ADHD treatment fails to impress; shares fall [Reuters (UK)]
SHIRE (SHPG)
Last shire earnings: 11/1 08:00 am
Check Earnings Report
US:NASDAQ Investor Relations:
investors.shire.com
Company Research
Source: Reuters
Supernus Pharma's ADHD treatment fails to impress; shares fall | Reuters 3 Min Read (Reuters) - Supernus Pharmaceuticals Inc’s treatment for attention deficit hyperactivity disorder met the main goal of two trials, but shares fell about 16 percent on Thursday as the data failed to convince some investors that the drug was better than rivals. Shares of the drugmaker fell as much as 15.8 pct to $38.75. The drug, SPN-812, is a non-stimulant and belongs to the same class of medicine as Eli Lilly and Co’s Strattera and Shire Plc’s Intuniv. Analysts on average said that SPN-812 has failed to stand out from existing treatment options for ADHD. But if Supernus is able to show that its drug takes effect quicker and causes fewer side effects than rival drugs, the company could benefit. The two placebo-controlled studies tested three doses of SPN-812 and the company said it proved effective in reducing symptoms such as hyperactivity and lack of attention in affected children aged six to 11 in bo
Show less
Read more
Impact Snapshot
Event Time:
SHPG
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
SHPG alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
SHPG alerts
High impacting SHIRE news events
Weekly update
A roundup of the hottest topics